HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
100.37
-0.24 (-0.24%)
Jun 2, 2025, 4:00 PM - Market closed
HealthEquity Stock Forecast
Stock Price Forecast
The 12 analysts that cover HealthEquity stock have a consensus rating of "Strong Buy" and an average price target of $117, which forecasts a 16.57% increase in the stock price over the next year. The lowest target is $100 and the highest is $130.
Price Target: $117 (+16.57%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HealthEquity stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 9 | 9 | 8 | 7 | 8 | 7 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 12 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $112 → $125 | Buy | Maintains | $112 → $125 | +24.54% | Jun 5, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $98 → $115 | Strong Buy | Maintains | $98 → $115 | +14.58% | Jun 5, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $94 → $104 | Hold | Maintains | $94 → $104 | +3.62% | Jun 4, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $112 → $117 | Buy | Maintains | $112 → $117 | +16.57% | Jun 4, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $110 → $125 | Strong Buy | Maintains | $110 → $125 | +24.54% | Jun 4, 2025 |
Financial Forecast
Revenue This Year
1.32B
from 1.20B
Increased by 9.60%
Revenue Next Year
1.45B
from 1.32B
Increased by 10.04%
EPS This Year
3.67
from 1.09
Increased by 236.54%
EPS Next Year
4.48
from 3.67
Increased by 22.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4B | 1.6B | 1.8B |
| Avg | 1.3B | 1.4B | 1.6B |
| Low | 1.3B | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.9% | 20.9% | 21.1% |
| Avg | 9.6% | 10.0% | 11.2% |
| Low | 5.8% | 3.3% | 1.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.89 | 4.87 | 5.99 |
| Avg | 3.67 | 4.48 | 5.38 |
| Low | 3.48 | 4.17 | 4.82 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 256.4% | 32.8% | 33.7% |
| Avg | 236.5% | 22.0% | 20.2% |
| Low | 219.2% | 13.8% | 7.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.